http://www.fpnotebook.com/
Essential Thrombocythemia
- See Also
- Epidemiology
- More common in women
- Symptoms and signs
- Common
- Less common
- Thrombotic events
- Bleeding events
- Differential Diagnosis
- Reactive Thrombocytosis
- Clonal Thrombocytosis
- Chronic myeloproliferative disorder
- Labs (rule-out differential diagnosis above)
- C-Reactive Protein (CRP) Normal
- Erythrocyte Sedimentation Rate Normal
- Fibrinogen Level Normal
- Bone Marrow Biopsy Normal
- Management
- Age Under 60 years
- Low risk patients
- Consider low dose Aspirin
- Intermediate risk patients
- Platelet Count <1500 x10^3/uL
- Anagrelide
- Low dose Aspirin
- Platelet Count >1500 x10^3/uL
- Anagrelide
- Platelet Count <1500 x10^3/uL
- High risk patients
- Hydroxyurea
- Anagrelide
- Low dose Aspirin
- Low risk patients
- High risk patients over age 60 years
- Low dose Aspirin
- Hydroxyurea
- Women of child bearing age
- Consider low dose Aspirin
- Interferon alfa in high risk patients
- Age Under 60 years
- Complications (low Incidence)
- Prognosis: Factors predictive of poor prognosis
- Age over 60 years
- Thrombosis history
- References
Thrombocythemia, Hemorrhagic (C0040028) | |
|---|---|
| Definition (MSH) | A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets. |
| Definition (CSP) | clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets. |
| Definition (NCI) | An increased number of thrombocytes (platelets) in the blood, without a known cause. |
| Definition (NCI) | A chronic myeloproliferative disorder that involves primarily the megakaryocytic lineage and it is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or hemorrhage. The cause is unknown. Median survival times of 10-15 years are commonly reported. (WHO, 2001) -- 2003 |
| Concepts | Disease or Syndrome (T047) |
| ICD9 | 238.71, 238.71 |
| MSH | D013920 |
| English | Essential haemorrhagic thrombocythaemia, Essential hemorrhagic thrombocythemia, Essential Thrombocytemia, Essential thrombocythaemia, Essential Thrombocythemia, Essential Thrombocythemias, Essential thrombocytosis, ESSNTIAL THROMBOCYTHEMIA, ET - Essential thrombocythaemia, ET - Essential thrombocythemia, Hemorrhagic Thrombocythemia, Hemorrhagic Thrombocythemias, Idiopathic haemorrhagic thrombocythaemia, Idiopathic hemorrhagic thrombocythemia, Idiopathic thrombocythaemia, Idiopathic thrombocythaemia -RETIRED-, Idiopathic Thrombocythemia, Idiopathic thrombocythemia -RETIRED-, Idiopathic Thrombocythemias, Primary Thrombocythemia, Primary Thrombocythemias, Primary thrombocytosis, THROMBOCYTHEMIA IDIOPATHIC |
| Spanish | trombocitemia esencial, trombocitemia esencial hemorragica, trombocitemia hemorragica esencial, trombocitemia idiopatica, trombocitemia idiopatica hemorragica, trombocitosis esencial, trombocitosis hemorragica idiopatica |
| Parent Concepts | Blood Platelet Disorders (C0005818), Neoplasm of uncertain behavior of other lymphatic and hematopoietic tissue (C0027632), Blood Coagulation Disorders (C0005779), Hemorrhagic Disorders (C0019087), thrombocytosis (C0836924), Chronic myeloproliferative disorder (C1292778), Megakaryocytic Neoplasm (C1334687), stage, chronic myeloproliferative disorders (C0279215), [X]Malignant neoplasms of lymphoid, hematopoietic and related tissue (C0348393), Duplicate concept (C1274013), Reason not stated concept (C1276325), Primary malignant neoplasm (C1306459), Disorder of hematopoietic morphology (C1532234) |
| Sources | COSTAR, CSP, DXP, ICD9CM, MSH, MTHICD9, NCI, NDFRT, OMIM, PDQ, QMR, SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System) |